13D/13G Filings - MPM BioVentures IV QP LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
4:08 pm
Purchase
2020-12-3113GChiasma, Inc.
CHMA
MPM BioVentures IV QP LP7,167,747
12.100%
13,000increase
(+0.18%)
Filing
History
2021-02-12
4:06 pm
Sale
2020-12-3113GSyndax Pharmaceuticals, Inc.
SNDX
MPM BioVentures IV QP LP0
0.000%
-2,242,658decrease
(Position Closed)
Filing
History